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Abstract
Background: Human neural stem cells (hNSC) have the potential to provide novel cell-based
therapies for neurodegenerative conditions such as multiple sclerosis and Parkinson's disease. In
order to realise this goal, protocols need to be developed that allow for large quantities of hNSC
to be cultured efficiently. As such, it is important to identify factors which enhance the growth of
hNSC. In vivo, stem cells reside in distinct microenvironments or niches that are responsible for
the maintenance of stem cell populations. A common feature of niches is the presence of the
extracellular matrix molecule, laminin. Therefore, this study investigated the effect of exogenous
laminin on hNSC growth.
Results: To measure hNSC growth, we established culture conditions using B27-supplemented
medium that enable neurospheres to grow from human neural cells plated at clonal densities.
Limiting dilution assays confirmed that neurospheres were derived from single cells at these
densities. Laminin was found to increase hNSC numbers as measured by this neurosphere
formation. The effect of laminin was to augment the proliferation/survival of the hNSC, rather than
promoting the undifferentiated state. In agreement, apoptosis was reduced in dissociated
neurospheres by laminin in an integrin β1-dependent manner.
Conclusion: The addition of laminin to the culture medium enhances the growth of hNSC, and
may therefore aid their large-scale production.
Background
Neural stem cells (NSC) have the ability to give rise to the
three main cell types of the central nervous system (CNS),
as well as being able to self-renew. As such, both public
and scientific attention has focussed on them as potential
therapies for neurodegenerative diseases, including multi-
ple sclerosis and Parkinson's disease. The scarcity of pri-
mary human tissue from which these NSC can be isolated
has generated a need to develop protocols that allow their
expansion in cell culture. As a first step towards this goal
it is necessary to identify and understand the factors that
regulate NSC growth and differentiation. Important clues
as to the identity of these factors come from the observa-
tion that the NSC are not randomly distributed through-
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out the brain. Instead, they reside within distinct
microenvironments or niches such as the ventricular/sub-
ventricular zone (VZ/SVZ) of the developing CNS and the
subependymal zone (SEZ) of the adult CNS [1,2]. Studies
of such niches from different tissues and organisms have
led to the identification of common signalling molecules
including growth factors, cell-cell signalling molecules,
adhesion molecules and extracellular matrix (ECM) mol-
ecules, and combinations of these are therefore likely to
provide strategies to maintain stem cell populations and
so enhance NSC growth in cell culture [3,4].
The demonstration that laminins make direct contact
with adult NSC via basal lamina-like extension from
blood vessels in the SVZ called fractones [5,6], and with
embryonic NSC via laminins expressed within the ven-
tricular zone [7-9], highlight the likely key role of these
ECM molecules in NSC regulation. Acting mainly through
the integrin family of receptors, the ECM is a key regulator
of all aspects of cell behaviour, including proliferation,
survival, migration and differentiation [10]. Integrins are
transmembrane αβ heterodimers that undergo a confor-
mational change upon ligand binding, thereby leading to
downstream effects such as actin polymerisation and syn-
ergism with growth factor signalling [10]. In other stem
cell systems, the ECM has been found to inhibit the termi-
nal differentiation of epidermal stem cells [11]. Similarly,
the properties of both embryonic and spermatogonial
stem cells can be maintained in vitro by growth on a lam-
inin substrate [12,13]. In agreement, the elevated expres-
sion of integrins, particularly the laminin-binding α6β1
heterodimer, has been used to isolate stem cells from
other, more differentiated cell types [14-20], and integrin
β1 has also been implicated in the maintenance of epider-
mal and prostate stem cells [21,22]. In contrast, less is
known about the role of laminin/integrin interactions on
human NSC (hNSC). They have been shown to promote
the migration of hNSC in an integrin α6-dependent man-
ner [23]; likewise a cholinergic neuronal fate is promoted
by laminin [24]. However, the role of laminins in hNSC
growth has not been examined. Here, we test the hypoth-
esis that recreating features of the niche microenviron-
ment by the addition of exogenous laminins promotes
human NSC growth and provides a strategy for improving
the efficiency of their propagation for translational
research use.
Methods
Reagents and antibodies
N2 and B27 culture supplements were purchased from
Gibco (Paisley, UK). Epidermal growth factor (EGF) and
fibroblast growth factor-2 (FGF-2) were obtained from
R&D Systems (Abingdon, UK). Accutase was purchased
from Millipore (Chandlers Ford, UK). The integrin β1-
stimulatory antibody, TS2/16, was purified from the
hybridoma culture supernatant (LGC-Promochem, Ted-
dington, UK) by incubation with Protein G beads (GE
Healthcare, Little Chalfont, UK) overnight at 4°C, before
being eluted according to the manufacturer's instructions.
Unless already sodium azide-free, antibodies used in
functional studies were dialysed overnight at 4°C in phos-
phate-buffered saline (PBS) using sterile Slide-a-lyzer cas-
settes (Pierce, Cramlington, UK). The sterile mouse IgG1
isotype control (clone W3/25) was purchased from Sero-
tec (Oxford, UK). Human placental laminin (hereafter
referred to as "laminin") was purchased from Sigma-
Aldrich, as were all other reagents (Poole, UK).
Human cell culture
Human fetal tissue (8–10 weeks postconception) was col-
lected in accordance with the arrangements for informed
consent recommended by the Polkinghorne Committee
(1989) and the UK Department of Health guidelines
(1995), and with the approval of the Addenbrooke's Hos-
pital Medical Research Ethics Committee (Cambridge,
UK). The hNSC from the cortex were propagated as free-
floating aggregates (neurospheres) and cellular expansion
prior to use in the studies described here was achieved
using a passaging method described in detail elsewhere
[25]. In brief, fresh tissue was initially dissociated in
trypsin and seeded at a density of 200,000 cells/ml in a
T75 flask containing Dulbecco's Modified Eagle's Medium
(DMEM)/HAMS F12 (3:1), supplemented with N2
(1:100), EGF, FGF-2 (both at 20 ng/ml) and heparin (5
μg/ml). Cultures were fed every 4–5 days by replacing half
the medium and spheres were passaged after 14 days
expansion by cutting into 200 μm sections using a McIl-
wain tissue chopper.
Neurosphere assay
Human neurospheres were dissociated with accutase
before live cells were sorted using a MoFlo flow cytometer
(DakoCytomation, Ely, UK) into 96-well plates (Nunc,
Roskilde, Denmark) at a density of 500 per well (1,500
cells per cm2). In the experiments using a limiting dilution
assay to determine the frequency of neurosphere-forming
cells, progressively decreasing numbers of cells were
plated per well. Neurosphere medium (200 μl), contain-
ing EGF, FGF-2 (both at 20 ng/ml), heparin (5 μg/ml) and
2% B27 together with laminin or antibodies at the con-
centrations indicated in the figure legends, was added per
well. Prior experiments examining the effects of different
laminin concentrations on mouse neurosphere numbers
showed no significant increase above 10 μg/ml (see Addi-
tional file 1 and Additional file 2), so this concentration
was used throughout for the studies on human cells. Cells
were fed every 4–5 days by replacing half of the medium,
and the number of neurospheres formed was counted
after 21 days in culture. For the purpose of this paper,
these are termed primary neurospheres.
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Secondary neurospheres were grown by collecting
together primary neurospheres from a particular treat-
ment group, dissociating them with accutase before re-
plating at the same density using the flow cytometer in
fresh medium in the absence of any antibodies or lam-
inin. All other details are as for primary spheres.
Conditioned medium
Conditioned medium had been exposed for 5 days to
neurospheres growing in a T75 flask (see 'human cell cul-
ture'), before being passed through a 0.45 μm filter to
remove cell debris. The percentage refers to the amount of
conditioned medium added; fresh DMEM/Hams F12 con-
stituted the remaining volume. An appropriate quantity of
growth factors (20 ng/ml EGF and FGF-2, 5 μg/ml
heparin) and supplements (1% N2 or 2% B27, as indi-
cated in the figure legends) were added according the final
volume.
Apoptosis analysis
Human neurospheres were dissociated using accutase and
grown for 24 hours in medium ± laminin (10 μg/ml). In
order to examine apoptosis, cells were incubated with
fluoroscein isothiocyanate (FITC) conjugated annexin V
for 15 min at room temperature in binding buffer
(Annexin V-FITC apoptosis detection kit I, BD Pharmin-
gen), before being analysed on at FACScan II flow cytom-
eter (Becton Dickinson, Oxford, UK), with at least 10000
events being collected per data file. Further analysis was
performed using Summit 3.0 software (DakoCytoma-
tion).
Statistics
For all neurosphere assays, 8 experimental replicates were
performed for each tissue sample. The n value recorded in
the figure legends refers to the number of biological repli-
cates. The data are presented as mean ± standard error. All
statistics were calculated according to the test described in
the figure legends, with p < 0.05 considered significant.
Results
Human NSC will grow at clonal density in B27-
supplemented medium
To test our hypothesis as to the role of exogenous lam-
inins, we needed to develop an assay that enables single
dissociated cells to reveal any stem cell properties in cul-
ture. Neurospheres provide a very widely used method to
grow NSC, with each neurosphere representing a 3D
aggregate generated from a single NSC and containing a
mixture of NSC and more differentiated cells [26].
Human NSC are commonly grown in N2 medium con-
taining 20 ng/ml FGF2 and EGF, and are passaged by
chopping the spheres into segments to be placed in fresh
medium. However this approach in which large fragments
are passaged does not allow accurate quantification of the
effect of laminins or other manipulations on single NSC.
First, therefore, we dissociated spheres passaged by chop-
ping into single cell suspensions and re-plated them in the
same medium at 1 cell/well. No neurospheres formed in
these cultures (not shown). Moreover, even when higher
cell plating densities of 2000, 1000 or 500 per well (10, 5
or 2.5 per μl) were examined, extremely low neurosphere
yields were observed, with only 0.036 ± 0.009%, 0.029 ±
0.007% or 0.063 ± 0.050% of the plated cells forming
neurospheres, respectively (not shown).
To ask whether these dissociated human NSC had the
potential to form larger numbers of spheres given more
appropriate growth conditions, we attempted to mimic
the much higher cell densities present in chopped spheres
by the addition of conditioned medium to the culture.
50% conditioned medium added to N2/FGF2/EGF led to
a 22-fold increase in the number of primary neurospheres
which formed when cells were plated at 500/well (Fig. 1A;
p < 0.001, n = 2). None of the other concentrations of con-
ditioned medium caused any significant change in neuro-
sphere generation.
We conclude from this that the potential of the dissoci-
ated human cells to behave as NSC is much greater than
as revealed by N2 medium, and that N2 does not there-
fore represent an appropriate choice of medium supple-
ment for assays of human NSC behaviour and laminin
effects. B27 supplement has been shown to increase the
survival in culture of a range of CNS cell types, including
rodent neural precursors, and is necessary to establish
human neurosphere cultures from primary tissue,
whereas N2 supplement is sufficient to maintain them
[25,27]. Therefore, we next examined the effect of B27
supplement on the human neurosphere assay (Fig. 1A).
When compared with N2 supplement, B27 led to a large
and significant increase in primary neurosphere forma-
tion, with 3.775 ± 0.320% versus 0.013 ± 0.013% of cells
forming primary neurospheres, respectively (p < 0.0001, n
= 2). Critically, neurosphere-conditioned medium did not
increase neurosphere formation in the presence of B27,
with 50% conditioned medium actually leading to a
decrease in neurosphere numbers (2.838 ± 0.149% versus
3.775 ± 0.320%, respectively. p < 0.05, n = 2). Conse-
quently, these results show that B27-supplemented
medium does enable human NSC to show stem cell prop-
erties in dissociated culture, and this was therefore used in
all subsequent assays.
Limiting dilution assays confirm that neurospheres provide 
a quantitative assay for human NSC
Prior to using neurospheres as a quantitative assay of stem
cell properties, it was necessary to show that the numbers
of spheres formed reflected the growth of single cells and
not aggregation of two or more cells after plating. To do
BMC Neuroscience 2008, 9:71 http://www.biomedcentral.com/1471-2202/9/71
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this, we used a limiting dilution assay (LDA) as an alter-
native method to the neurosphere assay for determining
the frequency of the neurosphere-initiating cell in a pop-
ulation. By measuring the likelihood of sphere formation
in progressively greater dilutions of dissociated cells, the
LDA calculates the number of individual cells able to form
spheres. The neurosphere-initiating frequency determined
by the LDA was 2.91 ± 0.23% (Fig. 1B), which was not sig-
nificantly different from the frequency calculated by the
neurosphere assay (Fig. 1A; 3.78 ± 0.32%; p = 0.19, n = 3
and n = 2 for the LDA and the neurosphere assay, respec-
tively). Therefore, as the two assays gave equivalent
results, neurosphere assays were used in future experi-
ments.
Laminin promotes hNSC growth
Having established the conditions for the human neuro-
sphere assay, the effect of soluble laminin was investi-
gated. After 21 days in culture, two-fold more primary
neurospheres had formed in the presence of laminin com-
pared to medium alone (Fig. 2A; p < 0.05, n = 2). When
these primary neurospheres were dissociated and replated
at the same clonal density but now in the absence of
added laminin, no difference in the number of secondary
neurospheres produced was observed (Fig. 2B; 8.63 ± 1.00
versus 7.00 ± 0.82 neurospheres per 500 cells for cells orig-
inally grown in medium or medium+laminin, respec-
tively). Therefore, laminin increased primary neurosphere
formation, but had no effect on secondary sphere growth.
This shows that the relative numbers of hNSC was not
increased by growth in laminin, suggesting that the effect
of the laminin responsible for increased numbers of pri-
mary spheres is on NSC proliferation/survival.
Augmented cell survival in the presence of laminin
The loss of attachment to the ECM usually leads to cells
undergoing anoikis [28]. Consequently, laminin in the
culture medium may prevent cells from undergoing apop-
tosis, leading to increased primary neurosphere forma-
tion. In order to investigate this, human neurosphere cells
were treated with laminin for 24 hrs before being stained
for the presence of phosphatidylserine in the external leaf-
let of the plasma membrane, a marker of apoptosis, by
FITC-conjugated annexin V (Fig. 2C) [29]. The resulting
data were normalised to the values seen with medium
alone. Laminin led to a decrease in annexin V staining,
with 73.69 ± 4.70% of cells being annexin V+ relative to
medium alone (p < 0.01; n = 5). As such, laminin
decreased apoptosis in cells dissociated from human neu-
rospheres.
Cell survival is mediated by integrin β1
Integrins are the main receptor family for the ECM, with
α3β1, α6β1, α7β1 and α6β4 mostly responsible for bind-
ing laminin [10]. The role of integrin subunit β1 in medi-
Conditions affecting the human neurosphere assayFigure 1
Conditions affecting the human neurosphere assay. 
(A) Dissociated neurosphere cells were plated at 500 cells 
per well in either 1% N2 or 2% B27 supplement, together 
with 0–100% neurosphere-conditioned medium. Relative to 
no conditioned medium (0%), a significant increase in neuro-
sphere formation was observed for 50% conditioned medium 
only in the presence of N2 supplement. In comparison, 50% 
conditioned medium significantly reduced neurosphere for-
mation in the presence of B27 supplement. Notably, human 
neurosphere formation was significantly increased by 2% B27 
supplement compared to 1% N2 supplement for all concen-
trations of conditioned medium, as determined by a one-way 
ANOVA with Tukey post-test (p < 0.001, n = 2). (B) Graph 
showing the result of the limiting dilution assay, with cells 
from dissociated human neurospheres being plated at 10–60 
cells per well in 2% B27 supplement. The number of non-
responding wells (i.e. without a neurosphere present) was 
quantified as a fraction of the total number of wells 21 days 
later. Linear regression was used to produce to the line of 
best fit. Unless otherwise noted, statistics were determined 
by a one-way ANOVA with Tukey post-test. n = 2 for all 
except for the limiting dilution assay, where n = 3. *p < 0.05.
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ating the effect of laminin on cell survival was investigated
further for two reasons (Fig. 2C). Firstly, integrin subunit
β4 is not expressed by human neurospheres [30]. Sec-
ondly, in parallel experiments using the much faster-
growing murine cells we found that integrin β1-blocking
antibodies negated the laminin-induced increase in neu-
rosphere numbers (see Additional file 3 and Additional
file 1). In the absence of laminin, adding an isotype con-
trol or integrin β1-blocking antibody to the human cell
cultures did not significantly alter the percentage of
annexin V+ cells relative to medium alone (99.52 ± 9.44%
and 115.90 ± 11.81%, respectively). However, in the pres-
ence of laminin, the integrin β1-blocking antibody led to
a significant rise in the percentage of annexin V+ cells,
increasing from 80.74 ± 2.03% in the presence of the iso-
type control antibody to 96.18 ± 0.94%, relative to
medium alone (p < 0.05, n = 3). Therefore, integrin β1 is
necessary for the laminin-mediated increase in survival.
Integrin activation is not sufficient to recapitulate the 
laminin effect
Human laminins are commonly isolated from placenta
[31]. This presents three problems to its use by the bio-
technology sector. First is the question of how to guaran-
tee sufficient supply. Secondly, laminin placental
preparations are heterogeneous. Depending on the purifi-
cation protocol, they contain different laminins that are
degraded to varying degrees, and in addition may contain
fibronectin [32]. Thirdly, there may be significant varia-
tion between batches from the same manufacturer [32]. In
contrast, the mouse Engelbreth-Holm-Swarm (EHS)
tumour produces relatively pure and un-degraded type of
laminin (laminin-111) [33]. However, in light of the
expression of non-human antigens by human embryonic
stem cells exposed to animal-derived culture supplements
[34], it is not suitable for growing cells to be used in ther-
apies. An alternative, more homogeneous and scaleable
solution is to use a monoclonal antibody to stimulate the
laminin receptor. Given the finding that laminin-depend-
ent survival was mediated by integrin β1, the question of
sufficiency was addressed using the integrin β1-activating
antibody TS2/16 [35]. The concentration of TS2/16 used
(10 μg/ml) was sufficient to activate integrin signalling, as
demonstrated by augmented integrin β1-dependent plate-
let adhesion and the increased phosphorylation of tyro-
sine 397 on focal adhesion kinase in human neurosphere
cells (see Additional file 4 and Additional file 1) [36,37].
However, when added to the hNSC culture medium, no
significant difference was observed in the number of pri-
mary (Fig. 3A) or secondary (Fig. 3B) neurospheres that
formed, compared to an isotype control antibody. There-
fore, β1 integrin activation alone was not sufficient to
increase neurosphere formation.
Laminin increases human primary neurosphere formationFigure 2
Laminin increases human primary neurosphere for-
mation. (A) Cells dissociated from human neurospheres and 
plated in medium alone or medium containing 10 μg/ml lam-
inin (Medium+Laminin). After 21 days, significantly more pri-
mary neurospheres had formed in the presence of laminin. 
(B) The neurospheres from (A) were dissociated and re-
plated in medium alone. Note that no laminin was added to 
the culture medium in (B). No difference in secondary neu-
rosphere numbers was observed. *p < 0.05, as determined 
by Student's t-test; n = 2. (C) Dissociated neurosphere cells 
were grown for 24 h in the absence (medium) or presence 
(Ln) of laminin, in addition to either an isotype control (Iso. 
Cont.) or integrin β1-blocking antibody (β1 block), before 
being analysed for annexin-V expression by flow cytometry. 
The number of annexin-V+ cells, relative to medium alone, is 
shown. Annexin V-binding was significantly reduced in the 
presence of laminin compared to medium alone, indicating an 
increase in cell survival. The addition of an integrin β1-block-
ing antibody returned the number of annexin V+ cells to con-
trol levels, indicating that laminin acts through integrin β1. 
Statistics were determined by a one-way ANOVA with 
Tukey post-test. n = 5 for medium and laminin, n = 3 for all 
other conditions. **p < 0.01, *p < 0.05.
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Growth factor and integrin signalling demonstrate con-
siderable cross-talk [36]. For example, high levels of plate-
let-derived growth factor (PDGF) negate any differential
effects of ECM substrates on oligodendrocyte prolifera-
tion [38]. As all cultures thus far had been supplemented
with 20 ng/ml EGF and FGF-2, we examined whether a
lower concentration (2 ng/ml) would allow any effects on
neurosphere formation of activating integrin signalling to
be observed (Fig. 3C, D). However, no significant effects
of the activating antibody were found at these lower
growth factor concentrations, either for the number of pri-
mary (Fig. 3C) or secondary neurospheres produced (Fig.
3D).
Discussion
The aim of this study was to investigate the role of lam-
inins in promoting human NSC growth. Laminin was
found to increase neurosphere formation and cell survival
in an integrin β1-dependent manner. However, integrin
β1 signalling alone was insufficient to recapitulate the
effect of laminin.
Culture medium requirements for growth of single hNSC
The increase in human neurospheres in the presence of
conditioned medium supports the observation that astro-
cyte-conditioned medium augments the proliferation of
mouse NSC [39-41]. The presence of astrocytes within
human neurospheres suggests that they could play a sim-
ilar role [42]. Whilst the identity of the secreted factors in
human neurosphere-conditioned medium remains to be
elucidated, candidates identified from rodent studies
include cystatin C, galectin-1 and pigment-derived epithe-
lial factor (PEDF) [43,44].
We show here that the addition of B27 supplement also
enables hNSC to generate neurospheres when plated at
low, clonal densities. B27 supplement is chemically
defined, containing the all ingredients present in N2 sup-
plement, as well as additional factors. However, it is diffi-
cult to assess whether the effect of B27 is due to an
individual factor, or the synergy of several. Interestingly,
B27 also contains the antioxidant enzymes superoxide
dismutase and catalase, which reduce oxidative stress and
promote cell survival [45,46]. Although human NSC have
been grown at low densities in other studies without B27
supplementation, this has been achieved by using the
additional mitogen, leukaemia inhibitory factor (LIF), as
well as EGF and FGF-2 [47]. LIF has been demonstrated to
have a powerful positive effect on hNSC proliferation via
the JAK-STAT pathway and it would be interesting to see if
compounds in B27 acted through similar mechanisms
[48].
Laminin promotes hNSC survival
Stem cell maintenance involves two issues: firstly, a prolif-
erative/survival component, and, secondly, the preserva-
tion of the undifferentiated state [49]. In this study,
laminin led to an increase in primary neurosphere num-
bers, but had no effect on secondary sphere formation.
This suggests that the effect of laminin was on NSC prolif-
eration or survival, rather than promoting the undifferen-
tiated (stem cell) state, as the latter would be predicted to
increase the number of secondary neurospheres formed
form dissociated primary spheres. In agreement, laminin
was found to decrease apoptosis in neurosphere cells in
an integrin β1-dependent manner. These findings support
work done by Leone and colleagues, who used Cre-LoxP
technology to excise integrin β1 from neural cells in vitro
[50]. They found that stem cell maintenance was unaf-
fected by the loss of the integrin, whilst cell death was
increased and proliferation was reduced. Preliminary pro-
liferation data indicates that laminin does not alter the
proportion of cells in S or G2/M phase (as determined by
propidium iodide incorporation and flow cytometry),
whereas the addition of EGF/FGF-2 does increase this pro-
portion. Therefore, whilst laminin-integrin β1 interac-
Activation of integrin β1 does not recapitulate the effects of lam ninFigure 3
Activation of integrin β1 does not recapitulate the 
effects of laminin. (A) Cells were dissociated from human 
neurospheres and plated at 500 cells per well in the presence 
of medium supplemented with either an isotype control anti-
body or a β1 integrin stimulatory antibody (TS2/16; both at 
10 μg/ml). Note that no alteration to the number of primary 
neurospheres which formed was observed. (B) Primary neu-
rospheres were dissociated and re-plated in medium alone. 
Again, TS2/16 had no effect on secondary neurosphere for-
mation. (C) As for (A), except that the cells were grown in 2 
ng/ml EGF and FGF-2, rather than 20 ng/ml. (D) Secondary 
neurosphere formation from the primary neurospheres in 
(C). Statistics were determined by a one-way ANOVA with 
Tukey post-test. (A) n = 5; (B) n = 4; (C, D) n = 2.
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tions mediate hNSC survival, a different ECM-integrin
combination appears to regulate proliferation.
At least two waves of apoptosis occur during CNS devel-
opment. Cell death is prominent amongst proliferating
neural stem/precursor cells and neuroblasts present in the
ventricular and intermediate zones in both rodents and
humans [51]. At later developmental stages, cell death
mainly happens in post-mitotic neurons that have failed
to innervate their targets [52]. The importance of cell
death in the stem/precursor populations is shown by
knock-outs of various components of the apoptotic path-
way in mice. These result in the malformation of the CNS,
with enlarged ventricular zones and disruption of the
cytoarchitecture [53-55]. As these alterations are apparent
from E9.5–E10.5, before neurogenesis commences, they
must reflect a requirement for regulated cell death in the
neural stem/precursor cells as part of normal develop-
ment.
The function of cell death at this early stage of CNS devel-
opment is uncertain, although the correction of spatial/
temporal errors, control of cell numbers or the selection
for particular neuronal phenotypes have all been sug-
gested (reviewed in [56,57]). The control of cell numbers
is particularly important, as mutations that lead to the
early loss of NSC during development cause microcephaly
[58]. Likewise, the upstream pathways are not widely
understood, although there are links with known regula-
tors of CNS development. For example, the receptor
Patched signals for cell death in neuroepithelial cells
unless it is bound by its ligand, Sonic hedgehog (Shh)
[59]. Similarly, signalling from receptor tyrosine kinases,
via mitogen-activated protein kinase (MAPK) and Akt
family members, also regulate apoptosis in the develop-
ing neuroepithelium [60-64]. This provides a potential
link between the extracellular matrix and apoptosis, as
integrins can activate MAPK pathways in rodent NSC [8].
Laminin-mediated effects require signals additional to 
integrin β1 activation
Integrin β1 activation failed to reproduce the increased
human NSC growth seen with laminin. There are three
potential explanations. Firstly, integrin β1 can form het-
erodimers with subunits α1–11, and αV, which together
can bind many ECM molecules including laminins, colla-
gens, tenascins and fibronectin [10]. The different ECM
molecules have a different effect on NSC behaviour
[23,65]. Therefore, it is possible that activating different
integrin β1 heterodimers results in opposite effects, lead-
ing to no net increase in NSC growth.
Secondly, integrin signalling is determined by both affin-
ity regulation, through conformational changes in the
subunits, and by avidity regulation, in which integrins are
clustered. Laminin may form a polymer, presenting mul-
tiple integrin binding sites and thus leading to both affin-
ity and avidity changes [28]. In contrast, it is likely that the
activating β1 integrin antibody increased affinity only and
did not cause integrin clustering. As it has been shown
that both processes are required for effective outside-in
signal transduction [66], the activating antibody may not
result in as complete a signalling response as seen with
laminin even though the blocking antibody shows the
integrin to be necessary for this signalling.
Thirdly, laminins have been shown to bind to a range of
receptors, including dystroglycan and syndecans [28,67].
Dystroglycan is expressed in both the VZ and cortical plate
of the embryonic brain [9]. However, mutant mice have
defects in neuronal migration, consistent with the cobble-
stone (type II) lissencephaly phenotype seen in human
congenital muscular dystrophy [68,69]. Therefore, it is
unlikely that dystroglycan is involved in NSC regulation.
However syndecans are also expressed in the VZ and co-
operate with integrins in the adhesion of embryonic
fibroblasts to fibronectin [9,70,71]. It remains to be exam-
ined whether such an interaction occurs in the response to
laminin by neurosphere cells and whether syndecans and
integrins together promote signalling in NSC in response
to ECM.
Limitations of the neurosphere assay
The neurosphere assay we have used here represents a
rapid and convenient method for assessing the number of
neural stem cells within a population. However, it is not
without its caveats. The main limitation is that cell types
other than neural stem cells may proliferate and form
spheres, based on the finding that hippocampal progeni-
tors are able to form neurospheres which can be main-
tained for up to three passages [72,73]. Similarly, transit-
amplifying type C cells in the adult brain can also produce
neurospheres [74,75]. Consequently, counting the
number of neurospheres is not necessarily the same as
counting the number of stem cells present in a popula-
tion. Therefore, the absolute numbers reported in this
study may be an over-calculation, with an effect of lam-
inin on the progenitors also possibly contributing to the
increased numbers of spheres seen. In order to distinguish
the growth of progenitors from NSC, maintaining neuro-
sphere cultures for at least five passages has been sug-
gested, although the exact number of passages required
remains debatable [76]. The best way to prove that any
effect is directly on the stem cells would be an in vivo
method such as the repopulating assay used for haemat-
opoietic stem cells, but this has yet to be adapted for the
nervous system.
The assay we have used also does not address the impact
on multipotentiality of growing hNSC in laminin. The
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priming of hNSC with FGF-2/heparin/laminin prior to in
vitro or in vivo differentiation resulted mainly in neurons
forming, whereas the fate of unprimed hNSC was biased
towards an astrocytic phenotype [77]. This is consistent
with the findings of other groups that laminin induces a
neuronal fate [78]. Moreover, laminin has also been
implicated in altering the subtype of neuron formed.
Human NSC primed as described above mostly formed
cholinergic neurons, in addition to smaller numbers of
glutamatergic and gamma-aminobutyric acid (GABAer-
gic) neurons [77]. Similarly, laminin has been found to
increase the ratio of GABAergic to glutamatergic neurons
compared to fibronectin [79]. Therefore, it would be
expected that the culture of hNSC in laminin would bias
the cells towards a neuronal fate.
Conclusion
The aim of this study was to examine the role of laminin
signalling in promoting human NSC growth, using an in
vitro assay to isolate the cells from other niche-derived fac-
tors. Laminin was shown to increase primary neurosphere
formation and the survival of human NSC. Integrin β1
was necessary for this process, but activation of this
integrin was not sufficient. Therefore, multiple receptors
or receptor complexes may be necessary in order for lam-
inin to promote hNSC growth. As it is likely that the
human placental preparation used in this study contains
a number of laminins including laminin-511 (LN-10,
α5β1γ1) [32], further work using recombinant laminins is
required to define the active laminin isoform and generate
reagents suitable for expanding hNSC appropriate for
therapeutic use.
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